Budapest, Hungary
We are one of the leading generic pharmaceutical companies in Central Eastern Europe, our activities incorporate all areas of the pharmaceutical value chain. Egis is a member of Servier, a global pharmaceutical group governed by a Foundation.
In the 2020/2021 business year Egis Group generated net sales of EUR 542 million. Besides Hungary, we sell our products under Egis’ brand names in 17 countries through our network of subsidiaries and representative offices.
Our products (active ingredients, tablets, injections, galenic formulations etc.) are available in 61 countries in total through our network of subsidiaries and representative offices or partners.
Our focus lies on treating diseases of the cardiovascular and central nervous systems and we also provide modern treatment solutions in the fields of oncology and women’s health. In 2013, we launched our first biosimilar monoclonal antibody (mAb) product, it was also the first mAb in the European Union. Since then, we launched 3 more biosimilar drugs.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Egis Pharmaceuticals on the Pharma Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
